A Brain Computer Interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interfaces (MMI), Direct Neural Interfaces (DNI), or Brain Machine Interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device. BCI differs from neuromodulator in that it allows for bidirectional information flow. BCI’s are often directed at researching, assisting, mapping, augmenting, or repairing human cognitive or sensory-motor functions.
The global market size of Brain Computer Interfaces (BCI) is US$ million in 2017 with $$ CAGR from 2013 to 2017, and it is expected to reach US$ million by the end of 2023 with a CAGR of $$% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end application/use segment and competitor segment. For geography segment, regional supply, type-wise demand and application wise, major players, price is presented from 2013 to 2023.
This report covers following regions:
North America, Asia & Pacific, Europe, South America, MEA (Middle East and Africa)
The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, France, UK, Germany, Italy, Spain, CIS, and Brazil etc.
The Compnaies Include:
Nerusky, Inc, Advanced Brain Monitoring, Artinis Medical Systems B.V, Elekta AB, ANT Neuro B.V, Nihon Kohden Corporation, Emotiv Systems, Inc, NeuroPace Inc, Blackrock Microsystems LLC, OpenBCI, Mindm et al.
For end application/use segment, this report focuses on the status and outlook for key applications. End users also can be listed. For competitor segment, the report includes global key players of Brain Computer Interface as well as some small players.
We also can offer customized reports to fulfill special requirements of our clients.